Abemaciclib API Manufacturer in India

WHO-GMP Certified Oncology API Supplier

Abemaciclib API Manufacturer India

Product Specifications

Product Name: Abemaciclib API
CAS Number: 1231929-97-7
Category: Active Pharmaceutical Ingredient
Grade: IP / BP / EP / USP
Appearance: Light yellow to off-white powder
Standards: IP / BP / EP / USP compliant

Abemaciclib API (CAS No: 1231929-97-7)

High-Quality Active Pharmaceutical Ingredient for Oncology Treatments

Abemaciclib API is a high-quality active pharmaceutical ingredient used in targeted cancer therapies, particularly for the treatment of breast cancer. It plays a crucial role in inhibiting cancer cell growth and improving patient outcomes.

As a reliable Abemaciclib API supplier, Swapnroop Drugs & Pharmaceuticals ensures consistent quality, high purity, and compliance with global pharmaceutical standards.

We are a GMP certified API manufacturer providing pharmaceutical companies worldwide with high-quality materials suitable for regulated markets.

Key Features

  • High purity and superior quality
  • GMP compliant manufacturing process
  • Excellent stability and consistency
  • Suitable for regulated markets
  • Bulk supply availability

Applications

  • Used in oncology drug formulations
  • Breast cancer treatment medications
  • Pharmaceutical research and development

Why Choose Us

  • Consistent and reliable bulk supply
  • Competitive global pricing
  • Regulatory documentation support
  • Efficient logistics and delivery

Packaging & Supply

Secure packaging in fiber drums with protective inner lining ensures product safety, stability, and integrity during transportation and storage.

Get Bulk Quote

Bulk Oncology API Manufacturer & Exporter in India

Swapnroop Pharma is a leading oncology API manufacturer in India offering high-quality pharmaceutical raw materials with consistent quality and global compliance.

Global Pharmaceutical API Supplier

We supply APIs worldwide with strong export capabilities, reliable logistics, and competitive pricing for pharmaceutical companies.